BioGaia AB - Interim management statement 1 January – 31 March 2018
Comments from the Managing Director: “Sales for the first quarter of 2018 amounted to SEK 157 million, which was an increase of 13% (excluding foreign exchange effects) compared to the corresponding period last year. Revenue for the first quarter of 2017 included compensation, from the agreement with Kabaya Ohayo in Japan, for knowhow, education and launch preparations. Adjusted for this revenue, sales rose by 18% (excluding foreign exchange effects).The growth in revenue was fueled mainly by robust development in the EMEA and Americas regions. I am also particularly pleased with the